Medicum, Faculty of Medicine, University of Helsinki, Helsinki 00290, Finland.
Macromolecular Crystallography Laboratory, National Cancer Institute, Basic Science Program, Leidos Biomedical Research Inc., Argonne, IL 60439, USA.
J Mol Biol. 2020 Jun 12;432(13):3749-3760. doi: 10.1016/j.jmb.2020.04.005. Epub 2020 Apr 14.
Optically controlled receptor tyrosine kinases (opto-RTKs) allow regulation of RTK signaling using light. Until recently, the majority of opto-RTKs were activated with blue-green light. Fusing a photosensory core module of Deinococcus radiodurans bacterial phytochrome (DrBphP-PCM) to the kinase domains of neurotrophin receptors resulted in opto-RTKs controlled with light above 650 nm. To expand this engineering approach to RTKs of other families, here we combined the DrBpP-PCM with the cytoplasmic domains of EGFR and FGFR1. The resultant Dr-EGFR and Dr-FGFR1 opto-RTKs are rapidly activated with near-infrared and inactivated with far-red light. The opto-RTKs efficiently trigger ERK1/2, PI3K/Akt, and PLCγ signaling. Absence of spectral crosstalk between the opto-RTKs and green fluorescent protein-based biosensors enables simultaneous Dr-FGFR1 activation and detection of calcium transients. Action mechanism of the DrBphP-PCM-based opto-RTKs is considered using the available RTK structures. DrBphP-PCM represents a versatile scaffold for engineering of opto-RTKs that are reversibly regulated with far-red and near-infrared light.
光控受体酪氨酸激酶(opto-RTKs)可利用光来调节 RTK 信号。直到最近,大多数 opto-RTKs 都是用蓝绿光激活的。将来自耐辐射球菌的细菌光敏色素(DrBphP-PCM)的光感核心模块与神经营养因子受体的激酶结构域融合,产生了可利用 650nm 以上光进行控制的 opto-RTKs。为了将这种工程方法扩展到其他家族的 RTKs,我们将 DrBpP-PCM 与 EGFR 和 FGFR1 的细胞质结构域结合。由此产生的 Dr-EGFR 和 Dr-FGFR1 opto-RTKs 可被近红外光快速激活,并被远红光失活。这些 opto-RTKs 能有效地触发 ERK1/2、PI3K/Akt 和 PLCγ 信号。opt-RTKs 和基于绿色荧光蛋白的生物传感器之间不存在光谱串扰,可实现 Dr-FGFR1 的同时激活和钙瞬变的检测。考虑到现有的 RTK 结构,我们认为 DrBphP-PCM 基 opto-RTKs 的作用机制是合理的。DrBphP-PCM 是一种多功能支架,可用于构建可被远红光和近红外光可逆调节的 opto-RTKs。